Carle Illinois professor named AIMBE fellow

March 5, 2021
bethhart@illinois.edu

Written by bethhart@illinois.edu

Carle Illinois College of Medicine professor Jennifer Amos has been named a fellow of the American Institute for Medical and Biological Engineering (AIMBE).

Amos, who is also a professor of bioengineering at The Grainger College of Engineering, was honored for her outstanding contributions to the development of curriculum and assessment methods in biomedical engineering and engineering-driven medical education. She has been actively involved in efforts across the biomedical engineering community during the COVID-19 pandemic.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences.

A formal induction ceremony will be held during AIMBE’s 2021 Annual Event on March 26 where Amos will be inducted along with more than 170 colleagues who make up the AIMBE Fellow Class of 2021.

About AIMBE

AIMBE’s mission is to recognize excellence in, and advocate for, the fields of medical and biological engineering in order to advance society. Since 1991, AIMBE’s College of Fellows has led the way for technological growth and advancement in the fields of medical and biological engineering. AIMBE Fellows have helped revolutionize medicine and related fields to enhance and extend the lives of people all over the world. They have successfully advocated for public policies that have enabled researchers and business-makers to further the interests of engineers, teachers, scientists, clinical practitioners, and ultimately, patients.

Editor’s note: Read the original version of this article written by Huan Song, Illinois Bioengineering here.


Share this story

This story was published March 5, 2021.